接种疫苗对住院COVID-19患者的心脏保护作用
Julian Madrid1, Prerana Agarwal2, Katharina Müller-Peltzer2
1Department of Cardiology, Pneumology, Angiology, Acute Geriatrics and Intensive Care, Ortenau Klinikum, Klostenstraße 19, 77933, Lahr/Schwarzwald, Germany. julian.madrid@ortenau-klinikum.de.
Clinical and experimental medicine
|May 17, 2024
概括
接种COVID-19疫苗显著减少急性心脏事件,并降低住院患者的心脏生物标志物. 这突显了接种疫苗对严重的COVID-19结果的心脏保护益处.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
背景情况:
- COVID-19疫苗接种是为了预防和减轻COVID-19的严重程度而建立的.
- 住院COVID-19患者面临心脏并发症的风险.
- 在这个人群中,COVID-19疫苗接种的心脏保护作用需要进一步调查.
研究的目的:
- 研究COVID-19疫苗接种在住院COVID-19患者中的心脏保护作用.
- 评估疫苗接种情况与急性心脏事件之间的关联.
- 为了评估疫苗接种对住院COVID-19患者心脏生物标志物水平的影响.
主要方法:
- 追溯的,单中心的队列研究.
- 包括确认疫苗接种状态的住院COVID-19患者 (2021年7月至2022年2月).
- 评估急性心脏事件,心脏生物标志物水平 (热素T) 和危险因素 (糖尿病,先前存在的心脏病).
主要成果:
- 接种疫苗的患者显示急性心脏事件的相对风险降低 (RR:0.33).
- 接种疫苗的个体表现出降低的托罗邦素T水平 (科恩d: -0.52).
- 2型糖尿病和先前存在的心脏病是急性心脏事件的重要危险因素.
结论:
- 接种COVID-19疫苗似乎为住院患者提供心脏保护性益处.
- 接种疫苗可以提供直接和间接的保护作用,防止COVID-19中的心脏并发症.
- 识别糖尿病和心脏病等危险因素对于治疗住院COVID-19患者至关重要.
相关概念视频
Vaccinations
44.4K
Overview
44.4K
Pneumonia V: Nursing management and Prevention
2.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.0K
Pneumonia IV: Management
323
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
323
Heart Failure Drugs: Inotropic Agents
573
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
573
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Pneumonia III: Complications and Assessment
203
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
203


